Ensayo clínico

INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery

NCT: NCT06965504 · NOT_YET_RECRUITING

ID NCTNCT06965504

EstadoNOT_YET_RECRUITING

Fecha de inicio2026-09-01

Finalización2029-06-01

SponsorAbiomed Inc. (INDUSTRY)

First posted2025-05-11

Last updated2026-09-10

Resumen breve

The study will evaluate the impact of a combined device-drug strategy with Impella 5.5 with best practices and optimized GDMT on heart recovery outcomes in patients with decompensated heart failure and cardiogenic shock.

Fuente oficial

Ver en ClinicalTrials.gov →

Datos obtenidos de la API de ClinicalTrials.gov. Para conocer el estado más reciente, consulte el registro oficial.